MARKET

MBRX

MBRX

Moleculin Biotec
NASDAQ
4.950
-0.130
-2.56%
After Hours: 5.07 +0.12 +2.42% 16:03 05/20 EDT
OPEN
5.01
PREV CLOSE
5.08
HIGH
5.07
LOW
4.810
VOLUME
13.98K
TURNOVER
0
52 WEEK HIGH
15.75
52 WEEK LOW
4.280
MARKET CAP
11.44M
P/E (TTM)
-0.3824
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MBRX last week (0513-0517)?
Weekly Report · 20h ago
Moleculin Biotech to Present Research at EHA2024 Hybrid Congress
TipRanks · 4d ago
Moleculin Biotech Initiates Phase 2 Glioblastoma Treatment Study
TipRanks · 5d ago
Moleculin Commences NIH-Funded Phase 2 Clinical Trial Of STAT3 Inhibitor For Glioblastoma
Benzinga · 5d ago
Moleculin Biotech Updates Investors with Corporate Presentation
TipRanks · 6d ago
Analysts’ Top Healthcare Picks: Moleculin Biotech (MBRX), MiNK Therapeutics (INKT)
TipRanks · 6d ago
Moleculin Biotech GAAP EPS of -$2.02
Seeking Alpha · 05/13 11:44
*Moleculin Biotech 1Q Loss/Shr $2.02 >MBRX
Dow Jones · 05/13 11:32
More
About MBRX
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. The Company has a pipeline of clinical programs for the treatment of tumors and viruses. It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio and WP1122 Portfolio. Annamycin is designed to avoid multidrug resistance mechanisms and cardiotoxicity. Its WP1066, is an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Its portfolio includes WP1193, and WP1220. Its WP1122 contains compounds including WP1096, and WP1097, which is designed to exploit the potential uses of inhibitors of glycolysis such as 2-deoxy-D-glucose (2-DG).

Webull offers Moleculin Biotech Inc stock information, including NASDAQ: MBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBRX stock methods without spending real money on the virtual paper trading platform.